The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT05034432
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT05034432
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05034432. Randomized; single masking; primary purpose treatment. Start 2022-05-27 (actual); primary completion 2027-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
- Acronym
- PIVATAL
- Condition
- Arrythmia
- Condition
- Cardiomyopathies
- Intervention (Procedure)
- Intra-Op Prophylactic VT ablation
- Intervention (Other)
- Conventional Management
- Lead sponsor
- University of Rochester
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct05034432- Content hash
53eca0dae16cb8eb29b24cdb608499ecf73bd0f8dd918b051e925931a2e1469d